StonvexLoading…
StonvexStonvexStonvexCore line items from PLRX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Q3 2024 2024-09-30 | Q2 2024 2024-06-30 |
|---|---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
Operating Income | $-156.37M | $-228.37M | $-175.04M | $-113.03M |
Net Income | $-149.34M | $-210.30M | $-160.57M | $-55.85M |
EPS (Diluted) | $-2.43 | $-3.47 | $-2.66 | $-1.71 |
Total Assets | $225.23M | $396.95M | $445.67M | $483.73M |
Total Liabilities | $44.02M | $92.87M | $99.84M | $91.05M |
Cash & Equivalents | $45.45M | $71.19M | $79.62M | $80.39M |
Free Cash Flow OCF − CapEx | $-128.71M | $-159.35M | $-111.48M | $-78.31M |
Shares Outstanding | 61.45M | 60.86M | 60.85M | 60.43M |